Friday 23 October 2026 · Edition of the day

Current editionPast editions →

The Skeptic's Daily

The day's biggest stories, taken apart. For each one: what is actually established, what is only asserted, the questions worth asking — and a plausibility score for the central claim, given everything currently known.

Stories
4
Average plausibility
71%
How to read the score
It rates how well the core claim is evidenced — not how important the story is, nor whether it is good or bad news.
RegionAllGlobalAfricaNorth AmericaSouth AmericaAsia-PacificEuropeMiddle East
TopicAllPoliticsConflict & SecurityBusinessScienceHealth
01HealthNorth America

Medicaid cuts feature in Valadao's California reelection contest

NPR reports that the Republican congressman voted to cut a program covering roughly six in ten district residents.

Republican Representative David Valadao is fighting for reelection in central California, according to NPR. The outlet reports that he voted to cut Medicaid last year and that the program covers 62% of his district's residents. Its summary rounds that coverage figure to six in ten.

What holds up

  • ✓NPR explicitly links Valadao's reelection contest to his vote to cut Medicaid.
  • ✓The headline's 62% coverage figure and the summary's six-in-ten description are consistent as an approximate statement.

What doesn't yet

  • ?The item supplies neither the coverage data's source and date nor the legislative text and voting record.
  • ?It does not quantify local coverage losses or establish how the vote will affect the election result.

Ask before you share

  • →What data support the district's Medicaid enrollment estimate?
  • →What would the voted-for cuts change for residents, and on what timetable?

Sources & original reporting

  1. [1]NPR · Published 22 Oct 2026 · npr.org
02HealthEurope

Research attributes 50,000 deaths in European cities to summer heat

The Guardian reports a record urban heat death toll, but the supplied excerpt does not show the study’s methods or uncertainty.

The Guardian reported that new research attributes 50,000 deaths in European cities this summer to heat, describing the total as a record. The report says death rates were highest in Malta, Italy and Hungary, with health issues, loneliness and poverty exacerbating the toll.

What holds up

  • ✓The Guardian explicitly bases the 50,000 figure on new research and links to a research publication.
  • ✓The reported scope is European cities, not all locations across Europe.

What doesn't yet

  • ?The excerpt does not provide the methodology, uncertainty interval or criteria used to attribute deaths to heat.
  • ?No other supplied outlet corroborates the estimate, and the basis for calling it a record is not shown.

Ask before you share

  • →How did the researchers estimate heat-attributable deaths, and what is the uncertainty range?
  • →Which cities and comparison years were included in the record claim?

Sources & original reporting

  1. [1]The Guardian · Published 23 Oct 2026 · theguardian.com
03HealthAfrica

Officials link reported Nigerian Ebola patient's travel history to Uganda

The BBC says the patient traveled to Kampala, but the excerpt does not establish where infection occurred.

The BBC reported that officials described Nigeria's first Ebola patient as having vacationed in Uganda. The summary identifies her as the wife of a diplomat based in Abuja and says she traveled to Kampala.

What holds up

  • ✓The BBC attributes the patient's Uganda travel history to officials.
  • ✓The summary specifies Kampala as the vacation destination and Abuja as the diplomat's base.

What doesn't yet

  • ?The excerpt supplies no diagnostic results, travel dates or evidence identifying the place of infection.
  • ?The scope of 'first' is unspecified; the item does not clarify the outbreak or reporting period.

Ask before you share

  • →What laboratory evidence confirms the diagnosis?
  • →What period does 'first patient' refer to, and what does contact tracing establish?

Sources & original reporting

  1. [1]BBC News · Published 22 Oct 2026 · bbc.co.uk
04HealthAfrica

Researcher says Guinea-Bissau newborn vaccine trial will not proceed

The Guardian reports that the US-backed hepatitis B study was halted after drawing international criticism.

The Guardian reported that a hepatitis B vaccine trial involving newborns in Guinea-Bissau would not move forward, citing its lead researcher. The study was to be funded by the CDC and had drawn global backlash.

What holds up

  • ✓The excerpt names researcher Frederik Schaltz-Buchholzer as the source of the announcement.
  • ✓It identifies the proposed study's location, vaccine focus and intended CDC funding.

What doesn't yet

  • ?The announcement comes from a study participant; no separate funder or regulatory confirmation is supplied.
  • ?The excerpt does not explain the trial design, grounds for criticism or whether research elsewhere remains possible.

Ask before you share

  • →Have the funder and relevant authorities confirmed the halt?
  • →Does the decision end the study entirely or only its proposed work in Guinea-Bissau?

Sources & original reporting

  1. [1]The Guardian · Published 21 Oct 2026 · theguardian.com